Comparison between the influence of roxadustat and recombinant human erythropoietin treatment on blood pressure and cardio-cerebrovascular complications in patients undergoing peritoneal dialysis

Comparison between the influence of roxadustat and recombinant human erythropoietin treatment on blood pressure and cardio-cerebrovascular complications in patients undergoing peritoneal dialysis

IntroductionRoxadustat treatment in PD patients is equivalent to ESAs in increasing hemoglobin (Hb). But blood pressure, cardiovascular parameters, cardio-cerebrovascular complications and prognosis in the two groups before and after treatment has not been sufficiently discussed.MethodsSixty PD pati...

Full description

Bibliographic Details
Main Authors: Shuiqin Cheng, Tingting Zhou, Le Yu, Zhihong Zhang, Yunmin Chen, Man Zhang, Jingjing Cui, Wenxin Yu, Jian Zhou, Yusheng Yu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Medicine
Subjects:
roxadustat
recombinant human erythropoietin
peritoneal dialysis
blood pressure
cardio-cerebrovascular complications
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2023.1166024/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2023.1166024/full

Similar Items